SCHEMBL1920404

SCHEMBL1920404

COC(CS(=O)(=O)O)NC=O

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.31
ADH1C P00326 1/20 0.31
ADH1A P07327 1/20 0.31
SLC22A6 Q4U2R8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1919900 0.76 ADH1B (0.32) ADH1BADH1CADH1A
SCHEMBL1919467 0.73
SCHEMBL7211769 0.72
SCHEMBL1919652 0.71
SCHEMBL11873574 0.70
SCHEMBL730294 0.70
SCHEMBL1920618 0.68 ADH1B (0.31) ADH1BADH1CADH1ASLC22A6
SCHEMBL18677607 0.67 ADH1B (0.30) ADH1BADH1CADH1A
SCHEMBL1920377 0.67 SLC6A4 (0.35) ADH1BADH1CADH1ASLC22A6
SCHEMBL2990953 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2326619-A2 METHIONINE ANALOGS AND METHODS OF USING SAME Bioxiness Pharmaceuticals, Inc. (US) 2011-06-01 EP disclosed
WO-2010014943-A2 METHIONINE ANALOGS AND METHODS OF USING SAME BIOXINESS PHARMACEUTICS, INC. (US) 2010-02-04 WO disclosed